Clinical Trial Update: Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating strategies to enhance adherence and knowledge of erlotinib in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer | NA | Status: COMPLETED